Houlihan Lokey shares are higher today, with the stock up about 3.37% to $147.93, as traders reverse some of the recent weakness that followed a notable price-target reduction. On April 6, BMO Capital lowered its price target on HLI to $166 from $192 while keeping an Outperform rating, effectively framing the prior pullback as overdone versus the revised target and helping invite dip-buying as the stock stabilized.

The price-target reset appears to have flushed out incremental sellers earlier in the week, leaving room for a snapback as broader market sentiment improved and investors rotated back into capital-markets-sensitive financials. With HLI still trading below the newly lowered $166 target, the setup today looks less like a single-company headline and more like a relief rally amplified by positioning after a quick rerating.

The next major fundamental checkpoint is the upcoming earnings print window in May, with market calendars pointing to mid-May timing for the next report. Investors will focus on whether advisory activity trends—particularly M&A-related fee events—continue to improve, and whether management commentary supports sustained momentum into the fiscal year-end.